1
|
O'Kelly F. Commentary to quantification of vesicoureteral reflux using machine learning. J Pediatr Urol 2024; 20:265-266. [PMID: 38097422 DOI: 10.1016/j.jpurol.2023.10.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Accepted: 10/12/2023] [Indexed: 04/22/2024]
|
2
|
Tsiakaras S, Langas G, Rafailidis V, Memmos D, Mykoniatis I, Asouhidou I, Karamitsou P, Sountoulides P, Kikidakis D, Vakalopoulos I, Paraskevas GK, Poutoglidis A. The Discovery of an S-shaped Kidney in a Patient With Prostate Cancer: A Rare Finding. Cureus 2024; 16:e51685. [PMID: 38313971 PMCID: PMC10838390 DOI: 10.7759/cureus.51685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/05/2024] [Indexed: 02/06/2024] Open
Abstract
Crossed fused renal ectopia (CFRE) constitutes a rare congenital anomaly of the urinary tract, typically characterized by its predominantly asymptomatic nature and frequent incidental discovery. This case report delineates the clinical profile of a 56-year-old male admitted to our Prostate Cancer Outpatient Clinic due to elevated prostate-specific antigen (PSA) levels, ultimately leading to the diagnosis of prostate cancer. The patient was asymptomatic, with no family or surgical background. Notably, a fused ectopic kidney was incidentally identified during the staging process involving abdominal computed tomography (ACT) scanning. Remarkably, no additional abnormalities of the urinary tract or renal dysfunction manifested in this specific case. The significance of this report lies in the underscored emphasis on the importance of employing precise imaging techniques and tailored management strategies for patients harboring such anatomical variations.
Collapse
Affiliation(s)
- Stavros Tsiakaras
- 1st Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, Thessaloniki, GRC
| | - Georgios Langas
- 1st Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, Thessaloniki, GRC
| | - Vasileios Rafailidis
- Clinical Radiology Department, School of Medicine, Aristotle University of Thessaloniki, AHEPA University Hospital of Thessaloniki, Thessaloniki, GRC
| | - Dimitrios Memmos
- 1st Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, Thessaloniki, GRC
| | - Ioannis Mykoniatis
- 1st Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, Thessaloniki, GRC
| | - Irene Asouhidou
- Department of Anatomy and Surgical Anatomy, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GRC
| | - Paraskevi Karamitsou
- Department of Otorhinolaryngology-Head and Neck Surgery, 'G. Papanikolaou' General Hospital, Thessaloniki, GRC
| | - Petros Sountoulides
- 1st Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, Thessaloniki, GRC
| | - Dimitrios Kikidakis
- 1st Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, Thessaloniki, GRC
| | - Ioannis Vakalopoulos
- 1st Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, Thessaloniki, GRC
| | - George K Paraskevas
- Department of Anatomy and Surgical Anatomy, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GRC
| | - Alexandros Poutoglidis
- Department of Otorhinolaryngology-Head and Neck Surgery, 'G. Papanikolaou' General Hospital, Thessaloniki, GRC
| |
Collapse
|
3
|
Nordenskjöld A, Lagerstedt-Robinson K, Anderlid BM, Lundin J. Tissue specific trisomy 15 mosaicism associated with urogenital malformations. Eur J Med Genet 2023; 66:104824. [PMID: 37633646 DOI: 10.1016/j.ejmg.2023.104824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 08/03/2023] [Accepted: 08/23/2023] [Indexed: 08/28/2023]
Abstract
We describe a boy born with hypospadias and later diagnosed with vesicoureteral reflux and mild cognitive disability. Routine diagnostic investigation by karyotyping, chromosomal microarray (CMA) and trio analysis with whole exome sequencing was normal. However, later CMA performed on DNA from genital tissue showed trisomy 15, which prompted further analysis. Fluorescent in situ hybridization was performed to verify the CMA result and delineate the mosaic rate. Methylation specific MLPA was performed to investigate the parent of origin of the extra chromosome 15. Further medical examination of the boy identified fine Blaschko's lines, indicative of mosaicism, but earlier unnoticed. CMA on genital tissue showed 80% mosaicism for trisomy 15. Bladder mucosa and muscle showed a high degree of trisomy 15 (56% and 45% respectively), while buccal mucosa and abdominal skin showed low-grade or no trisomy 15. The extra chromosome 15 was of maternal origin. This case report describes a boy with two different malformations in the same organ region that carries a high degree of trisomy 15 mosaicism. Hence, the clinical implication is that there is no recurrence risk for sibs, but the boy in his turn risks producing gametes with an extra chromosome 15. Tissue restricted mutations are not commonly described but may cause congenital malformations that affects the information to the family.
Collapse
Affiliation(s)
- Agneta Nordenskjöld
- Department of Women's and Children's Health and Center for Molecular Medicine, Karolinska Institutet, SE-17176, Stockholm, Sweden; Paediatric Surgery, Astrid Lindgren Children Hospital, Karolinska University Hospital, SE-17176, Stockholm, Sweden.
| | - Kristina Lagerstedt-Robinson
- Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, SE-17176, Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, SE-17176, Stockholm, Sweden.
| | - Britt-Marie Anderlid
- Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, SE-17176, Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, SE-17176, Stockholm, Sweden.
| | - Johanna Lundin
- Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, SE-17176, Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, SE-17176, Stockholm, Sweden.
| |
Collapse
|
4
|
Oguz F, Yildiz T, Gecit I, Gungor H, Ciftci H, Aksoy Y, Yagmur I. Efficacy and safety of Hyadex for treatment of vesicoureteral reflux: a multicenter experience. J Int Med Res 2023; 51:3000605231195165. [PMID: 37646623 PMCID: PMC10469260 DOI: 10.1177/03000605231195165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Accepted: 07/31/2023] [Indexed: 09/01/2023] Open
Abstract
OBJECTIVE This study was performed to evaluate the efficacy and safety of dextranomer/cross-linked hyaluronic acid (Hyadex) in patients with a clinical diagnosis of vesicoureteral reflux (VUR). METHODS In this cross-sectional multicenter observational study, Hyadex was used in four different centers for the endoscopic treatment of VUR from 2020 to 2022. The study involved 74 patients (93 renal units) who were diagnosed with VUR according to voiding cystourethrography (VCUG) findings and were considered suitable for subureteric endoscopic treatment. The follow-up time (control VCUG time) was 3 months. RESULTS In the VCUG evaluation, grade I VUR was found in 13 renal units, grade II in 23 renal units, grade III in 42 renal units, and grade IV in 12 renal units. The success rates of Hyadex treatment according to the degree of VUR were as follows: 84.6% for grade I, 82.6% for grade II, 71.4% for grade III, and 66.0% for grade IV. No major complications were observed. CONCLUSION Endoscopic subureteric Hyadex injection had high success rates in appropriately selected patients with VUR and may be used as the first-line treatment for children with VUR.
Collapse
Affiliation(s)
- Fatih Oguz
- Department of Urology, Inonu University Faculty of Medicine, Malatya, Türkiye
| | - Turan Yildiz
- Department of Pediatric Surgery, Inonu University Faculty of Medicine, Malatya, Türkiye
| | - Ilhan Gecit
- Department of Urology, Inonu University Faculty of Medicine, Malatya, Türkiye
| | - Hasan Gungor
- Department of Urology, Inonu University Faculty of Medicine, Malatya, Türkiye
| | - Halil Ciftci
- Department of Urology, Faculty of Medicine, Harran University, Malatya, Türkiye
| | - Yılmaz Aksoy
- Department of Urology, Atatürk University Faculty of Medicine, Malatya, Türkiye
| | - Ismail Yagmur
- Department of Urology, Faculty of Medicine, Harran University, Malatya, Türkiye
| |
Collapse
|